Literature DB >> 15486469

Lipids and the elderly.

Wilbert S Aronow1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15486469     DOI： 10.1023/B:REMD.0000045108.30411.2b

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   6.514


× No keyword cloud information.
  50 in total

Review 1.  Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials.

Authors:  P R Hebert; J M Gaziano; K S Chan; C H Hennekens
Journal:  JAMA       Date:  1997 Jul 23-30       Impact factor: 56.272

2.  The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators.

Authors:  F M Sacks; M A Pfeffer; L A Moye; J L Rouleau; J D Rutherford; T G Cole; L Brown; J W Warnica; J M Arnold; C C Wun; B R Davis; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-03       Impact factor: 91.245

3.  Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up.

Authors: 
Journal:  Lancet       Date:  2002-04-20       Impact factor: 79.321

4.  Correlation of serum lipids with the presence or absence of atherothrombotic brain infarction and peripheral arterial disease in 1,834 men and women aged > or = 62 years.

Authors:  W S Aronow; C Ahn
Journal:  Am J Cardiol       Date:  1994-05-15       Impact factor: 2.778

5.  Serum cholesterol as a prognostic factor after myocardial infarction: the Framingham Study.

Authors:  N D Wong; P W Wilson; W B Kannel
Journal:  Ann Intern Med       Date:  1991-11-01       Impact factor: 25.391

6.  Effect of an educational program on the prevalence of use of antiplatelet drugs, beta blockers, angiotensin-converting enzyme inhibitors, lipid-lowering drugs, and calcium channel blockers prescribed during hospitalization and at hospital discharge in patients with coronary artery disease.

Authors:  Shirin Sanal; Wilbert S Aronow
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2003-11       Impact factor: 6.053

7.  Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study.

Authors:  J R Downs; M Clearfield; S Weis; E Whitney; D R Shapiro; P A Beere; A Langendorfer; E A Stein; W Kruyer; A M Gotto
Journal:  JAMA       Date:  1998-05-27       Impact factor: 56.272

8.  Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.

Authors:  Steven E Nissen; E Murat Tuzcu; Paul Schoenhagen; B Greg Brown; Peter Ganz; Robert A Vogel; Tim Crowe; Gail Howard; Christopher J Cooper; Bruce Brodie; Cindy L Grines; Anthony N DeMaria
Journal:  JAMA       Date:  2004-03-03       Impact factor: 56.272

9.  Prevalence of severe arteriosclerosis obliterans in patients with diabetes mellitus. Relation to smoking and form of therapy.

Authors:  K W Beach; J D Brunzell; D E Strandness
Journal:  Arteriosclerosis       Date:  1982 Jul-Aug

10.  Association of abnormal serum lipids in elderly persons with atherosclerotic vascular disease and dementia, atherosclerotic vascular disease without dementia, dementia without atherosclerotic vascular disease, and no dementia or atherosclerotic vascular disease.

Authors:  Vana Suryadevara; Samantha G Storey; Wilbert S Aronow; Chul Ahn
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2003-09       Impact factor: 6.053
View more
  5 in total

1.  Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study.

Authors:  Marco Bertolotti; Carlotta Franchi; Marco B L Rocchi; Andrea Miceli; M Vittoria Libbra; Alessandro Nobili; Giulia Lancellotti; Lucia Carulli; Chiara Mussi
Journal:  Drugs Aging       Date:  2017-04       Impact factor: 3.923

Review 2.  Metabolic syndrome in the elderly.

Authors:  Matthew Bechtold; John Palmer; Joshua Valtos; Catherine Iasiello; James Sowers
Journal:  Curr Diab Rep       Date:  2006-02       Impact factor: 4.810

3.  Comparison of percentage body fat and body mass index for the prediction of inflammatory and atherogenic lipid risk profiles in elderly women.

Authors:  Silvana Schwerz Funghetto; Alessandro de Oliveira Silva; Nuno Manuel Frade de Sousa; Marina Morato Stival; Ramires Alsamir Tibana; Leonardo Costa Pereira; Marja Letícia Chaves Antunes; Luciano Ramos de Lima; Jonato Prestes; Ricardo Jacó Oliveira; Maurílio Tiradentes Dutra; Vinícius Carolino Souza; Dahan da Cunha Nascimento; Margô Gomes de Oliveira Karnikowski
Journal:  Clin Interv Aging       Date:  2015-01-13       Impact factor: 4.458

4.  Effects of aging and menopause on pancreatic fat fraction in healthy women population: A strobe-compliant article.

Authors:  Wenjuan Yang; Yi Xie; Bin Song; Chunchao Xia; Chengwei Tang; Jing Li
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

5.  Age-associated alterations in cholesterol homeostasis: evidence from a cross-sectional study in a Northern Italy population.

Authors:  Marco Bertolotti; Chiara Mussi; Elisa Pellegrini; Alessandro Magni; Marina Del Puppo; Silvia Ognibene; Lucia Carulli; Claudia Anzivino; Enrica Baldelli; Paola Loria; Nicola Carulli
Journal:  Clin Interv Aging       Date:  2014-03-17       Impact factor: 4.458
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.